Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission

Trends in Molecular Medicine

Volumn 14, Issue 1, 2008, Pages 12-19

  de Witte, Lot ^a   Nabatov, Alexey ^a   Geijtenbeek, Teunis B H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; LANGERIN;

ANTIVIRAL ACTIVITY; CELL FUNCTION; DENDRITIC CELL; HOST PARASITE INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LANGERHANS CELL; NONHUMAN; PROTECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SEXUAL TRANSMISSION; VIRUS TRANSMISSION;

ANTIGENS, CD; CELL ADHESION MOLECULES; DENDRITIC CELLS; HIV INFECTIONS; HUMANS; LANGERHANS CELLS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; RECEPTORS, CELL SURFACE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 38049086957     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2007.11.001     Document Type: Review

References (55)

1. Shattock R.J., and Moore J.P. Inhibiting sexual transmission of HIV-1 infection. Nat. Rev. Microbiol. 1 (2003) 25-34
2. Anon. (2005) UNAIDS: global AIDS epidemic just beginning. AIDS Policy Law 20, 1
3. Steinman R.M., et al. The interaction of immunodeficiency viruses with dendritic cells. Curr. Top. Microbiol. Immunol. 276 (2003) 1-30
4. de Witte L., et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat. Med. 13 (2007) 367-371
5. McCoombe S.G., and Short R.V. Potential HIV-1 target cells in the human penis. AIDS 20 (2006) 1491-1495
6. Jameson B., et al. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J. Virol. 76 (2002) 1866-1875
7. Galvin S.R., and Cohen M.S. The role of sexually transmitted diseases in HIV transmission. Nat. Rev. Microbiol. 2 (2004) 33-42
8. Lederman M.M., et al. Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat. Rev. Immunol. 6 (2006) 371-382
9. Geijtenbeek T.B.H., et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100 (2000) 587-597
10. Trumpfheller C., et al. Cell type-dependent retention and transmission of HIV-1 by DC-SIGN. Int. Immunol. 15 (2003) 289-298
11. Arrighi J.F., et al. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J. Exp. Med. 200 (2004) 1279-1288
12. + cells in human rectal mucosa. J. Virol. 79 (2005) 5762-5773
13. Boggiano C., et al. Dendritic cell-mediated trans-enhancement of human immunodeficiency virus type 1 infectivity is independent of DC-SIGN. J. Virol. 81 (2007) 2519-2523
14. Magerus-Chatinet A., et al. Galactosyl ceramide expressed on dendritic cells can mediate HIV-1 transfer from monocyte derived dendritic cells to autologous T cells. Virology 362 (2007) 67-74
15. Nguyen D.G., and Hildreth J.E. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur. J. Immunol. 33 (2003) 483-493
16. Turville S.G., et al. Diversity of receptors binding HIV on dendritic cell subsets. Nat. Immunol. 3 (2002) 975-983
17. de Witte, L. et al. Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1. Proc. Natl. Acad. Sci. U. S. A. (in press)
18. Wu L., and Kewal Ramani V.N. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat. Rev. Immunol. 6 (2006) 859-868
19. Burleigh L., et al. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells. J. Virol. 80 (2006) 2949-2957
20. Turville S.G., et al. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 103 (2004) 2170-2179
21. McDonald D., et al. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300 (2003) 1295-1297
22. Wiley R.D., and Gummuluru S. Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 738-743
23. Cavrois M., et al. In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions. PLoS. Pathog. 3 (2007) e4
24. Kwon D.S., et al. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity 16 (2002) 135-144
25. Lee B., et al. cis expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J. Virol. 75 (2001) 12028-12038
26. Moris A., et al. DC-SIGN promotes exogenous MHC-I restricted HIV-1 antigen presentation. Blood 130 (2003) 2648-2654
27. Pion M., et al. APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection. J. Exp. Med. 203 (2006) 2887-2893
28. Hodges A., et al. Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication. Nat. Immunol. 8 (2007) 569-577
29. Betts M.R., et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75 (2001) 11983-11991
30. Lu W., et al. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat. Med. 10 (2004) 1359-1365
31. + T cells: HIV antigen presentation, T-cell activation, and viral transfer. Blood 108 (2006) 1643-1651
32. Smith A.L., et al. Leukocyte-specific protein 1 interacts with DC-SIGN and mediates transport of HIV to the proteasome in dendritic cells. J. Exp. Med. 204 (2007) 421-430
33. Buseyne F., et al. MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nat. Med. 7 (2001) 344-349
34. Harman A.N., et al. HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells. J. Immunol. 177 (2006) 7103-7113
35. Gringhuis S.I., et al. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-κB. Immunity 26 (2007) 605-616
36. Granelli-Piperno A., et al. HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7669-7674
37. Reece J.C., et al. HIV-1 selection by epidermal dendritic cells during transmission across human skin. J. Exp. Med. 187 (1998) 1623-1631
38. Zaitseva M., et al. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat. Med. 3 (1997) 1369-1375
39. Patterson B.K., et al. Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am. J. Pathol. 161 (2002) 867-873
40. Prakash M., et al. Chemokine receptor expression on mucosal dendritic cells from the endocervix of healthy women. J. Infect. Dis. 190 (2004) 246-250
41. Valladeau J., et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12 (2000) 71-81
42. Kawamura T., et al. R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8401-8406
43. Kawamura T., et al. PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes. J. Virol. 78 (2004) 7602-7609
44. Zhu T., et al. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261 (1993) 1179-1181
45. Hladik F., et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26 (2007) 257-270
46. Miller C.J., and Hu J. T cell-tropic simian immunodeficiency virus (SIV) and simian-human immunodeficiency viruses are readily transmitted by vaginal inoculation of rhesus macaques, and Langerhans' cells of the female genital tract are infected with SIV. J. Infect. Dis. 179 (1999) S413-S417
47. Fahrbach K.M., et al. Activated CD34-derived Langerhans cells mediate transinfection with human immunodeficiency virus. J. Virol. 81 (2007) 6858-6868
48. van der Aar A.M., et al. Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition. J. Immunol. 178 (2007) 1986-1990
49. Flacher V., et al. Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. J. Immunol. 177 (2006) 7959-7967
50. McDermott R., et al. Reproduction of Langerin/CD207 traffic and Birbeck granule formation in a human cell line model. J. Invest. Dermatol. 123 (2004) 72-77
51. Hunger R.E., et al. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J. Clin. Invest. 113 (2004) 701-708
52. Jimenez-Flores R., et al. High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract. Immunology 117 (2006) 220-228
53. Rebbapragada A., et al. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract. AIDS 21 (2007) 589-598
54. + T cells. Science 286 (1999) 1353-1357
55. Veazey R.S., et al. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature 438 (2005) 99-102